Does SUMATRIPTAN Cause Reversible cerebral vasoconstriction syndrome? 105 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 105 reports of Reversible cerebral vasoconstriction syndrome have been filed in association with SUMATRIPTAN (sumatriptan succinate). This represents 0.6% of all adverse event reports for SUMATRIPTAN.
105
Reports of Reversible cerebral vasoconstriction syndrome with SUMATRIPTAN
0.6%
of all SUMATRIPTAN reports
7
Deaths
49
Hospitalizations
How Dangerous Is Reversible cerebral vasoconstriction syndrome From SUMATRIPTAN?
Of the 105 reports, 7 (6.7%) resulted in death, 49 (46.7%) required hospitalization, and 7 (6.7%) were considered life-threatening.
Is Reversible cerebral vasoconstriction syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SUMATRIPTAN. However, 105 reports have been filed with the FAERS database.
What Other Side Effects Does SUMATRIPTAN Cause?
Drug ineffective (2,941)
Product physical issue (2,349)
Application site erythema (1,875)
Drug dose omission (1,711)
Product quality issue (1,269)
Application site pain (1,217)
Migraine (978)
Headache (914)
Product complaint (718)
Nausea (702)
What Other Drugs Cause Reversible cerebral vasoconstriction syndrome?
ESCITALOPRAM OXALATE (165)
FLUOXETINE (154)
TACROLIMUS (127)
METHYLPREDNISOLONE (119)
VENLAFAXINE (105)
DULOXETINE (102)
SERTRALINE (102)
MYCOPHENOLATE MOFETIL (68)
CITALOPRAM HYDROBROMIDE (64)
PAROXETINE (60)
Which SUMATRIPTAN Alternatives Have Lower Reversible cerebral vasoconstriction syndrome Risk?
SUMATRIPTAN vs SUMATRIPTAN\SUMATRIPTAN
SUMATRIPTAN vs SUMAVEL DOSEPRO
SUMATRIPTAN vs SUNITINIB
SUMATRIPTAN vs SUNITINIB MALATE
SUMATRIPTAN vs SUTENT